Independent Newspaper Nigeria on MSN

Benue NTD campaign reaches over 5 million persons, exposes drug diversion

Benue State’s campaign against neglected tropical diseases has reached more than five million people, but alleged drug diversion, inaccurate treatment reports and weak supervision threaten its ...
The Lancet

Dora Buonfrate—making strongyloidiasis less neglected

While being raised in the Republic of San Marino, neglected diseases were not something Dora Buonfrate ever thought about during her quiet and happy childhood. “But for as long as I can remember, I ...
BIOENGINEER

Adults Harbor Hidden Worm Burdens in Cameroon’s Rainforest, Threatening Parasite Elimination Goals

A new study in Cameroon's Nkam-Wouri River Basin finds that 41.9 percent of adults in rural rainforest communities carry ...
BIOENGINEER

Parasite-Derived MicroRNA Attenuates Liver Fibrosis in Mice

A Schistosoma japonicum-derived microRNA reduced liver fibrosis in carbon-tetrachloride-treated mice alongside lower stellate ...

Can Crohn's disease be cured by modern medicine?

Treatment methods for Crohn's disease in modern medicinePreviously, I wrote on my blog that Crohn's disease occurs in the ...
PR Newswire

OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®, now commercially available in the U.S.

Celltrion USA, Inc. today announced the availability of OMLYCLO® (omalizumab-igec), the first and only U.S. Food and Drug Administration ...
english.nepalnews

Snakebites kill 1,000 people annually in Nepal

KATHMANDU: Approximately 20,000 people are bitten by snakes annually in Nepal, resulting in about 1,000 deaths, according to ...
Modern Ghana

Trials on child-friendly formulation of ivermectin in the offing

Ghanaian science researchers are playing a leading role in an international effort to expand the use of a prescription ...
MarketScreener

Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced an expansion of their long-standing antibody collaboration, adding multiple next-generation, long-acting antibodies to the ...
The Barre-Montpelier Times Argus

Asahi Kasei to Integrate Global Pharmaceutical Brand Under Asahi Kasei Therapeutics

Asahi Kasei announced that Asahi Kasei Therapeutics in Japan, Veloxis Pharmaceuticals in the United States, Calliditas Therapeutics in Sweden ...

TEZSPIRE positive results from Phase III CROSSING trial in eosinophilic esophagitis including symptom improvement, histologic and endoscopic remission presented at United ...

Full results from the positive Phase III CROSSING trial showed that AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab) demonstrated statistically significant and clinically meaningful improvements in the ...
FT Markets

TEZSPIRE® DELIVERED HISTOLOGIC REMISSION AND SYMPTOM IMPROVEMENT IN EOSINOPHILIC ESOPHAGITIS

Amgen (NASDAQ:AMGN) and AstraZeneca today announced full results from the positive Phase 3 CROSSING trial that showed TEZSPIRE ® (tezepelumab-ekko) demonstrated statistically significant and ...